PT1254209E - Composicao compreendendo acido hidroxicitrico e garcinol para perda de peso - Google Patents

Composicao compreendendo acido hidroxicitrico e garcinol para perda de peso

Info

Publication number
PT1254209E
PT1254209E PT01977759T PT01977759T PT1254209E PT 1254209 E PT1254209 E PT 1254209E PT 01977759 T PT01977759 T PT 01977759T PT 01977759 T PT01977759 T PT 01977759T PT 1254209 E PT1254209 E PT 1254209E
Authority
PT
Portugal
Prior art keywords
garcinol
anthocyanin
composition
hca
reduction
Prior art date
Application number
PT01977759T
Other languages
English (en)
Inventor
Majeed Muhammed
Badmaev Vladimir
Original Assignee
Sabinsa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sabinsa Corp filed Critical Sabinsa Corp
Publication of PT1254209E publication Critical patent/PT1254209E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
PT01977759T 2000-08-17 2001-08-17 Composicao compreendendo acido hidroxicitrico e garcinol para perda de peso PT1254209E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22582100P 2000-08-17 2000-08-17

Publications (1)

Publication Number Publication Date
PT1254209E true PT1254209E (pt) 2006-08-31

Family

ID=22846386

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01977759T PT1254209E (pt) 2000-08-17 2001-08-17 Composicao compreendendo acido hidroxicitrico e garcinol para perda de peso

Country Status (12)

Country Link
US (1) US7063861B2 (pt)
EP (1) EP1254209B1 (pt)
JP (2) JP4205943B2 (pt)
AT (1) ATE320248T1 (pt)
AU (1) AU773081B2 (pt)
CA (1) CA2387548A1 (pt)
DE (1) DE60118019T2 (pt)
DK (1) DK1254209T3 (pt)
ES (1) ES2260293T3 (pt)
NZ (1) NZ518116A (pt)
PT (1) PT1254209E (pt)
WO (1) WO2002014477A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4205943B2 (ja) * 2000-08-17 2009-01-07 サビンサ コーポレーション 天然および合成ｈｃａのバイオアベイラブルな組成物
US20030187055A1 (en) * 2002-02-25 2003-10-02 Riker Donald K. Synergistic pharmaceutical combinations for treating obesity
US7507421B2 (en) * 2002-04-30 2009-03-24 Unibar Corporation Hydroxycitric acid salt composition and method of making
US8394856B2 (en) * 2002-07-02 2013-03-12 Glykon Technologies Group, Llc (-)-Hydroxycitric acid for controlling inflammation
EP1633328A4 (en) * 2003-05-29 2008-07-09 Glykon Technologies Group Llc METHOD AND COMPOSITION FOR STABLE AND CONTROLLED ADMINISTRATION OF (-) - HYDROXYCITRIC ACID
WO2005007088A2 (en) * 2003-07-03 2005-01-27 Unibar Corporation Stabilized anthocyanin extract from garcinia indica
US20050009919A1 (en) * 2003-07-07 2005-01-13 Clouatre Dallas L. Treating cachexia and excessive catabolism with (-)-hydroxycitric acid
US20080207952A1 (en) * 2003-10-09 2008-08-28 Muhammed Majeed Novel therapeutic applications of natural poly isoprenylated benzophenone derivatives as drugs/medicaments
US7386111B2 (en) * 2004-02-10 2008-06-10 Vonage Network Inc. Method and apparatus for placing a long distance call based on a virtual phone number
EP1781116A4 (en) 2004-06-04 2009-07-29 Horizon Science Pty Ltd NATURAL SWEETENER
US8021697B2 (en) 2005-06-03 2011-09-20 Horizon Science Pty. Ltd. Substances having body mass redistribution properties
AU2007299581B2 (en) 2006-09-19 2011-04-28 Poly Gain Pte Ltd Extracts derived from sugar cane and a process for their manufacture
US20080095867A1 (en) * 2006-10-19 2008-04-24 Renaissance Herbs, Inc. Hydroxycitric acid compositions from garcinia cambogia and hibiscus sp., methods of making, and therapeutic uses of same
CA2686419A1 (en) * 2007-05-04 2008-11-13 Nutraceutic Et Business Consulting Composition having lipolytic activity, production method thereof and use of the composition
JP5117762B2 (ja) * 2007-05-18 2013-01-16 株式会社半導体エネルギー研究所 液晶表示装置
US20090062231A1 (en) * 2007-08-31 2009-03-05 O'mara Ann Marie Appetite Suppressant Composition and Method of Appetite Suppression
US20100233306A1 (en) * 2009-03-16 2010-09-16 Sevanti Mehta Methods and compositions for weight loss using garcinia indica fruit puree
PT2658374E (pt) * 2010-12-30 2016-03-04 Majeed Muhammed Atividade hepatoprotetora do garcinol
US8329743B2 (en) * 2011-01-10 2012-12-11 Sami Labs Limited Compositions and its use in treating obesity or inducing weight loss
US9572852B2 (en) 2011-02-08 2017-02-21 The Product Makers (Australia) Pty Ltd Sugar extracts
MY171216A (en) 2012-08-28 2019-10-02 The Product Makers Australia Pty Ltd Extraction method
AU2014306366B9 (en) 2013-08-16 2020-03-26 Poly Gain Pte Ltd Sugar cane derived extracts and methods of treatment
US10285961B2 (en) 2014-02-06 2019-05-14 University Of Houston System Organic acids as agents to dissolve calcium minerals in pathological calcification and uses thereof
KR101781365B1 (ko) * 2016-08-31 2017-09-25 주식회사 코씨드바이오팜 반응표면분석법을 이용하여 가르시니아 캄보지아로부터 하이드록시 시트르산을 고수율로 추출하는 방법
JP2020523373A (ja) * 2017-06-15 2020-08-06 サミ ラブズ リミテッド ガルシノールの抗肥満の潜在能力
WO2019212929A1 (en) * 2018-04-30 2019-11-07 Muhammed Majeed Compositions for weight loss
GB2623571A (en) * 2022-10-21 2024-04-24 Mootral Innovations Ltd Compositions for reducing methane emission

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
US6294190B1 (en) * 1995-12-26 2001-09-25 Suntory Limited Antiobestic agent containing procyanidin as the active ingredient
JPH10203968A (ja) * 1997-01-27 1998-08-04 Munekazu Iinuma 抗腫瘍剤
JPH10265397A (ja) * 1997-03-25 1998-10-06 Toyotama Kenko Shokuhin Kk 肥満予防剤
JPH111431A (ja) * 1997-06-10 1999-01-06 Nichiyaku Kk 肥満抑制剤
JPH11139965A (ja) * 1997-11-06 1999-05-25 Kikkoman Corp 抗腫瘍薬
JP2000044468A (ja) * 1998-07-29 2000-02-15 Kikkoman Corp リパーゼ阻害剤及び抗肥満剤又は高脂血症抑制剤
JP2000072665A (ja) * 1998-08-31 2000-03-07 Kikkoman Corp ヒアルロニダーゼ阻害剤
WO2000012080A1 (en) 1998-09-01 2000-03-09 Amway Corporation Diet composition and method of weight management
FR2790645B1 (fr) 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
JP2000355536A (ja) * 1999-06-10 2000-12-26 Kikkoman Corp 発癌予防薬
FR2804319B1 (fr) * 2000-01-28 2002-10-25 Clarins Lab Composition cosmetique amincissante comprenant en tant qu'agent actif un extrait de plante contenant de l'anp
JP4205943B2 (ja) * 2000-08-17 2009-01-07 サビンサ コーポレーション 天然および合成ｈｃａのバイオアベイラブルな組成物

Also Published As

Publication number Publication date
AU9685101A (en) 2002-02-25
JP4205943B2 (ja) 2009-01-07
AU773081B2 (en) 2004-05-13
DE60118019T2 (de) 2006-11-02
ES2260293T3 (es) 2006-11-01
CA2387548A1 (en) 2002-02-21
EP1254209A2 (en) 2002-11-06
DK1254209T3 (da) 2006-07-24
DE60118019D1 (de) 2006-05-11
NZ518116A (en) 2005-06-24
US20020187943A1 (en) 2002-12-12
EP1254209A4 (en) 2004-09-08
JP2004506657A (ja) 2004-03-04
WO2002014477A2 (en) 2002-02-21
JP2008110996A (ja) 2008-05-15
EP1254209B1 (en) 2006-03-15
US7063861B2 (en) 2006-06-20
WO2002014477A3 (en) 2002-08-01
ATE320248T1 (de) 2006-04-15

Similar Documents

Publication Publication Date Title
PT1254209E (pt) Composicao compreendendo acido hidroxicitrico e garcinol para perda de peso
BRPI0519803A2 (pt) métodos para purificar trans-(-)-delta9-tetraidrocanabinol e trans-(+)-delta9-tetraidrocanabinol
BR0317149A (pt) Métodos para uso de uma composição para bebidas
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
EP1281398A4 (en) DERMAL COMPOSITIONS HAVING COENZYME Q AS ACTIVE INGREDIENT
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
BR9702074A (pt) Compostos biaril heterocíclicos composições farmacêuticas e cosméticas que os contêm e suas utilizações
BR0306306A (pt) Composição contendo extrato de matricária e uso desta
BRPI0411608A (pt) derivado de 8-aza-biciclo [3.2.1] octano, composição farmacêutica, uso do composto, e, método de tratamento, prevenção ou alìvio de uma doença, um distúrbio ou uma condição de um organismo animal vivo
DE60230961D1 (de) Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung
RU2011120054A (ru) Композиции для лечения эпителиальной ткани
DE69703820T2 (de) Diaromatische propynyl- oder dienylverbindungen
BR0008865A (pt) Composições contendo fluoreto estanhoso para o tratamento de dentes hipersensìveis
BR0214196A (pt) Método e composição para reduzir a atividade de inibir o crescimento de uma célula cancerosa, para tratar de paciente com câncer
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
BRPI0418854A (pt) composições herbáceas
BRPI0409387A (pt) método para o tratamento de doença de tecido mole em um indivìduo mamìfero, composição farmacêutica, complexo de alvejamento de tecido mole, método para a formação de um complexo, e, kit para uso em um método
BRPI0410576A (pt) composto quìmico, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, método para o tratamento, prevenção ou alìvio de uma doença ou um distúrbio ou condição de um corpo de animal vivo
RU2673075C1 (ru) Защитный крем для участков кожи с ограниченным воздухообменом
ATE368383T1 (de) Gewürzkrautzubereitung
BR0318123A (pt) Composição para o tratamento do cabelo, método para a preparação de uma composição, método para o tratamento do cabelo e usos de uma composição
BR0204185A (pt) Uso de substâncias agonistas de canais de k+ para prevenir ou tratar danos teciduais promovidos por ácido metil-malÈnico, composição farmacêutica compreendendo substâncias agonistas, composição para o tratamento ou prevenção de danos teciduais, composição compreendendo o uso de substâncias agonistas para uso no tratamento ou prevenção de danos teciduais, bem como composições apresentáveis em quaisquer formas farmacêuticas compreendendo substância agonista para uso no tratamento ou prevenção de danos teciduais
MX9710466A (es) Compuestos de estilbeno que contienen un grupo adamantilo, composiciones que los contienen y sus usos.
MX9605916A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticos y cosmeticas que los contienen y utilizaciones.